Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis

作者全名："Deng, Zhuofan; Zhang, Wenfeng; Peng, Junwei; Gao, Linxiao; Zhang, Chunyu; Lei, Kai; Gong, Jianping; Xiong, Bin"

作者地址："[Deng, Zhuofan; Zhang, Wenfeng; Gao, Linxiao; Zhang, Chunyu; Lei, Kai; Gong, Jianping; Xiong, Bin] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Peng, Junwei] Chongqing Med Univ, Dept Pediat Surg Oncol, Childrens Hosp, Chongqing, Peoples R China"

通信作者："Xiong, B (通讯作者)，Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing, Peoples R China."

来源：CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001200381000001

JCR分区：Q2

影响因子：2.8

年份：2024

卷号：　

期号：　

开始页：　

结束页：　

文献类型：Article; Early Access

关键词：Controlling nutritional status; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Prognostic factor

摘要："PurposeThis study aims to evaluate the prognostic value of controlling nutritional status (CONUT) score in determining the prognosis of patients with hepatocellular carcinoma (HCC) treated with conventional transcatheter arterial chemoembolization (cTACE).MethodsThis study retrospectively analyzed 936 patients who underwent cTACE for HCC between January 2012 and December 2018, and divided them into two groups based on their CONUT score. To balance the bias in baseline characteristics, propensity score matched (PSM) analysis was conducted. The Kaplan-Meier method was used to establish a cumulative survival curve, and the log-rank test was employed to determine differences in overall survival (OS) and progression-free survival (PFS) among the CONUT score groups. Furthermore, the Cox proportional hazard model was employed to assess the correlation between CONUT score and OS and PFS, whereby hazard ratios (HRs) and 95% confidence intervals (95% CIs) were computed.ResultsBefore PSM, the median OS for the low (<= 3) and high (>= 4) CONUT group (558 vs. 378 patients) was 21.7 and 15.6 months, respectively, and the median PFS was 5.7 and 5 months. Following PSM, both the low and high CONUT score groups comprised 142 patients. The low CONUT score group exhibited a significantly longer OS compared to the high CONUT score group, as determined by the log-rank test (median OS 22.2 vs. 17.0 months, P = 0.014). No significant association was observed between CONUT group and PFS (median PFS 6.4 vs. 4.7 months, log-rank test, P = 0.121). Cox proportional hazard regression analysis revealed that a CONUT score of >= 4 was an independent risk factor for OS in patients with HCC who underwent cTACE (HR = 1.361; 95% CI: 1.047-1.771; P = 0.022). These findings were consistent across most subgroup analyses.ConclusionA high CONUT score has been found to be a prognostic factor for poorer OS in patients with HCC who underwent cTACE.Level of EvidenceLevel 3, Non-randomized controlled cohort."

基金机构：　

基金资助正文：